Mainolfi Nello sold KYMR
December 8, 2025 · Form 4 insider transaction
Mainolfi Nello sold 100,000 shares of Kymera Therapeutics, Inc. at $89.17 per share, a transaction worth $8.92M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
100,000
Price
$89.17
Total value
$8.92M
InsiderMainolfi Nello
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 8, 2025
Filing dateDecember 8, 2025
Shares owned after660,482
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.